The clinical distinction between community-acquired pneumonia and health care-associated pneumonia is crucial for correct management and antibiotic selection. ... Consider aspiration pneumonia especially when two or more risk factors are present and
Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. ... A prediction rule to identify allocation of inpatient care in community-acquired pneumonia.
Only a positive study has diagnostic value. Aspiration pneumonia (implying infection), aspiration pneumonitis (suggesting chemically induced injury and inflammation), and even aspiration bronchitis are all classified as“ complex” pneumonias,
acquired pneumonia (CAP), 238 with health care-associated pneumonia (HCAP), 140 with hospital-acquired pneumonia (HAP), and 55 with ventilator-associated pneumonia (VAP). ... The frequency of multidrug-resistant pathogens varied across pneumonia types
Proton-pump inhibitors (PPIs) may be associated with a higher risk for postoperative pneumonia after coronary artery bypass grafting (CABG) than H. ... hospitals. The study's main outcome measure was postoperative pneumonia. The results were published
The researchers used logistic regression models to determine the association between screening status and pneumonia rate. ... Heightened vigilance in those who fail screening could help with identifying and treating pneumonia, the authors said.
Pneumonia is best confirmed by chest X-ray or chest computed tomography (CT). ... See the May 2011 Coding Corner column for a discussion of these types of pneumonia.).
A labeling change for doripenem (Doribax) warning about risk of death for ventilator patients with pneumonia. ... Doripenem is not approved to treat any type of pneumonia. It is still considered safe and effective for its FDA-approved indications:
A new indication for a pneumococcal 13-valent conjugate vaccine (Prevnar 13) to prevent pneumonia and invasive disease caused by Streptococcus pneumoniae in people ages 50 years and older.
Corticosteroids for patients hospitalized with community-acquired pneumonia (CAP) reduced length of stay but had no significant effect on overall mortality and increased risk for readmission and hyperglycemia, according to a